Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Businessweek Archives

Synthetic Poisons That Kill Cancer But Not People


Developments to Watch

SYNTHETIC POISONS THAT KILL CANCER BUT NOT PEOPLE

The combination of a natural poison and scientists' ingenuity may result in a new class of potent cancer drugs. In 1987, researchers found that certain types of soil bacteria produce substances, called enediynes, that are downright "diabolical," says chemist K.C. Nicolaou of the Scripps Research Institute in La Jolla, Calif.

The molecular equivalent of a Trojan horse, the substances innocently enter cells and home in on their genes. Then, when activated by a chemical signal, they turn deadly, destroying the genes--and the cells. Because the enediynes are such powerful assassins, scientists immediately wondered if they could fight cancer. But the poisons have a fatal flaw: They kill normal as well as tumor cells. Researchers set out to make synthetic enediynes, hoping to target only tumors.

Nicolaou's team appears to have succeeded by fashioning an enediyne that's more potent in killing leukemia and other cancers than are such current drugs as vinblastin and taxol. Yet, in lab and animal experiments described on May 22 in Science magazine, it didn't harm normal cells. The researchers don't know exactly why, but they're convinced that man-made enediynes will be important in the anticancer battle.EDITED BY FLEUR TEMPLETON


LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus